Laboratoire HRA-Pharma SAS – LYSODREN – Bristol-Myers Squibb Company « Commission for Protection of Competition
A-AA+
Republic of SerbiaCommission for Protection of Competition
Home » Resoultions » Laboratoire HRA-Pharma SAS – LYSODREN – Bristol-Myers Squibb Company
Title Session Date Resolution
Laboratoire HRA-Pharma SAS – LYSODREN – Bristol-Myers Squibb Company 20.02.2018 2018-151-Decision-on-approving-concentration-in-summary-procedure20febr2018
Republic of Serbia

Commission for Protection of Competition

Savska 25/IV,11000 Belgrade, Serbia
Tel: + 381 (0) 11 38 11 911
office.kzk@kzk.gov.rs